| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.1 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.079 | 0.1 |
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | -0.22 | 0.1 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.076 | 0.1 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | -0.27 | 0.1 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.083 | 0.1 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.12 | 0.1 |